Gincoben

Quick links to important sections

Gincoben

Selected form

Method of action: Psychoanaleptics

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gincoben

What is Gincoben? (Standardized Ginkgo biloba Extract)

Property Description
Active ingredient Standardized Ginkgo biloba extract
Form Tablet, Capsule, Oral Solution
Pharmacological class Phytomedicine / Nootropic Agent
Common use Cognitive support and relief of minor circulatory issues
Origin Natural/Derived (from Ginkgo biloba leaf)

What is Gincoben and How is it Classified?

Gincoben is a specific, standardized pharmaceutical preparation derived from the leaves of the Ginkgo biloba tree, which is explicitly classified as a Phytomedicine or Herbal Medicinal Product in European regulatory documents. This classification is clinically recognized for its potential use in addressing age-related cognitive impairment. Gincoben primarily functions as a nootropic agent intended for oral administration and is typically available as film-coated tablets or capsules, primarily targeting the aging adult population with a focus on product quality and consistency.


What is the Active Ingredient in Gincoben?

The sole active ingredient in Gincoben is a highly refined and standardized Ginkgo biloba extract, often known by the research designation EGb 761. This rigorous standardization ensures a consistent, verified chemical profile containing two primary groups of phytochemicals: Flavonoid glycosides and Terpene lactones. The presence of these specific compounds in verified quantities is a key factor differentiating high-quality preparations, as the extract’s known physiological actions are directly linked to these components.


What is the General Purpose of Gincoben?

The general purpose of Gincoben is to offer functional support for systems reliant on robust microcirculation and cellular protection. By possessing vasoactive properties, it helps to support blood flow to the brain and peripheral extremities, while its neuroprotective activity offers defense against cellular stress. Consequently, Gincoben is generally purposed for supporting healthy cognitive function, such as concentration, and assisting with symptoms related to compromised peripheral circulation, such as persistent coldness in the hands and feet.

Regulatory References

  1. Herbal medicinal products (EMA)
  2. Ginkgo biloba (DrugBank)

What side effects are possible with Gincoben?

Possible Side Effects and Safety Information

The safety profile for Gincoben, a standardized Ginkgo biloba extract, is defined by regulatory classifications that categorize potential adverse reactions by both frequency and the physiological system affected. The most frequently documented reactions tend to involve the Gastrointestinal System and the Nervous System.


Adverse Reaction Classifications

Official regulatory documents classify adverse reactions based on clinical reporting frequency:

Classification Examples of Reactions
Common Headache, dizziness, and diarrhea.
Uncommon Nausea, vomiting, abdominal pain, and allergic skin reactions (e.g., urticaria).
Not Known Bleeding events and difficulty breathing (dyspnea), as part of severe hypersensitivity.

Documented Safety Risks and Constraints

The most serious safety concern documented in official labeling is the potential for bleeding events, which can include outcomes such as cerebral or ocular hemorrhage. This risk is classified under Blood and Lymphatic System Disorders and is the basis for key safety constraints.

Regulatory documentation states that Gincoben is contraindicated in individuals with a known hypersensitivity to the extract or its components. Specific caution and use restrictions apply to individuals with a pre-existing bleeding tendency and those who are taking anticoagulants (such as warfarin) or antiplatelet agents (such as aspirin) due to the documented increase in the risk of bleeding. Furthermore, the extract is generally restricted from use prior to surgical procedures.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for standardized Ginkgo biloba extract (Gincoben) notes that there are no specific reports of human overdose available. Consequently, no precise symptoms for acute overexposure are documented in official labeling.

Overexposure Risk Profile Regulator-Mandated Action
Documented Manifestations No specific clinical signs reported due to lack of human data.
Serious Potential Outcomes High intake levels carry a theoretical risk of serious events, including bleeding (hemorrhagic tendency) and the potential for seizures.
Required Management Symptomatic and supportive treatment is the mandated approach, as no specific antidote is known or documented.

When to Seek Immediate Medical Help

Urgent medical attention is required immediately upon the suspicion of overexposure to Gincoben, especially if the patient exhibits any signs of severe adverse effects. This includes the manifestation of uncontrolled bleeding events (e.g., severe nosebleed, internal bleeding) or the new onset of seizures, which are potential complications associated with high intake. Clinical staff will initiate symptomatic and supportive treatment. Hospital monitoring may be necessary for continuous observation and to manage the potential for delayed serious outcomes. This protocol reflects the high-level regulatory guidance for managing overexposure.

Therapeutic Uses of Gincoben

The core therapeutic uses of standardized Ginkgo biloba extract, the active component of Gincoben, are considered relevant within two primary domains. The preparation may be part of symptomatic management for age-related decline and minor circulation problems.


Symptomatic Support and Primary Uses

Gincoben is commonly used for the symptomatic treatment of mild-to-moderate age-related cognitive impairment and certain forms of dementia, particularly those with a vascular component, as well as for peripheral circulatory disorders and associated neurosensory symptoms like vertigo and tinnitus. It helps address symptom clusters such as memory lapses, reduced concentration, and difficulties with attention.

Its application contributes to easing the overall symptom load and may assist with maintaining functional stability.


Quick Fact: Supportive Relief for Discomfort

The extract is applied across domains where additional symptomatic support is needed, helping to ease discomfort associated with conditions like intermittent claudication and persistently cold hands and feet. The core benefit contributes to improved comfort during periods of heightened symptoms and helps patients cope more steadily with symptom fluctuations.

Regulatory References

  1. European Medicines Agency therapeutic overview

Eligibility and Restrictions for Use

The regulatory profile for Gincoben (Standardized Ginkgo biloba Extract) strictly defines who may and may not use the medicine based on age, pre-existing conditions, and physiological state. All eligibility and non-eligibility rules are defined by authoritative governmental documentation.

Classification Regulatory Status
Populations Allowed Adults 18 years of age and older.
Populations Contraindicated Pregnancy; Hypersensitivity to the active substance or excipients.
Age-Related Status Use is not recommended for children and adolescents under 18 years due to insufficient established data.
Conditional Use Patients with epilepsy or a pathologically increased bleeding tendency.
Classification Context of Restriction
Lactation Status Use during breastfeeding is not recommended as risk to the infant cannot be excluded.
Procedural Restriction Must be discontinued prior to elective surgery (e.g., two weeks before).
Excipient Restriction Certain tablet formulations are contraindicated for patients with specific metabolic disorders (e.g., lactose-related deficiencies).

The official documentation establishes clear rules for non-eligibility, primarily through contraindications for pregnancy and hypersensitivity. For other groups, such as those with a predisposition to bleeding or a history of seizures, the regulatory assessment specifies conditional use or caution. These rules govern the product's use for its intended population of adults and older people.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures Gincoben's interaction profile across pharmacodynamic and pharmacokinetic mechanisms, defining specific co-administration constraints. The extract possesses anti-platelet activity, and co-administration with anticoagulants (such as Warfarin) or anti-platelet agents (such as Aspirin) may lead to an increased risk of bleeding.

Pharmacokinetic and Transporter Interactions

Substance / System Officially Documented Interaction Pattern
Efavirenz (Antiretroviral) Co-administration is not recommended. The extract may cause CYP3A4 induction, which can result in decreased plasma concentrations of Efavirenz.
CYP Enzymes Documented potential for moderate induction of CYP3A4, CYP2C9, and CYP2C19.
P-glycoprotein (P-gp) Studies indicate potential for inhibition at the intestinal level, which may increase the systemic exposure of P-gp substrate drugs (e.g., Dabigatran etexilate).

Administration Constraints

The regulatory profile formally advises that Gincoben should be discontinued at least 2 weeks prior to any surgical procedures to manage potential bleeding risks. Furthermore, a history of epilepsy is a population-specific consideration, as the onset of further seizures following intake cannot be excluded.

Mechanism of Action

How Gincoben Works

Gincoben's mechanism involves multi-target engagement by its standardized components, primarily the Flavonoid glycosides and Terpene lactones, which engage three key physiological domains that influence vascular and neuronal processes.


Dual Modulation of Microcirculation and Blood Flow

This core mechanism is initiated by the Terpene lactones, which act as antagonists against the Platelet-Activating Factor (PAF) receptor. This molecular blockade reduces platelet aggregation and modulates blood flow characteristics, which, combined with the extract's influence on endothelial cell vasodilation, leads directly to enhanced microcirculatory perfusion and systemically in peripheral tissues.


Neuroprotection and Cellular Energy Stabilization

  • The extract provides a defense against cellular degradation by addressing oxidative stress and influencing mitochondrial function. Flavonoid glycosides directly scavenge Reactive Oxygen Species (ROS), and Bilobalide stabilizes the neuronal mitochondrial membrane. This combined action helps preserve cellular integrity and maintain energy (ATP) production, which influences neuronal viability.

Chronic Modulation of Catecholamine Neurotransmission

Gincoben influences neural communication through the reversible inhibition of the Monoamine Oxidase A (MAO-A) enzyme, which slows the catabolism of key neurotransmitters like dopamine and norepinephrine. This modulation leads to a gradual, sustained increase in the functional availability of these catecholamines in synaptic circuits, influencing catecholamine-dependent signaling in CNS circuits.

Dosage and Administration Information

The use of Gincoben, a standardized Ginkgo biloba extract, is governed by instructions specifying oral administration only, via tablets, capsules, or oral solutions. The daily dose range is set between 120 mg and the maximum recommended 240 mg of the extract. Dosing for comprehensive support often uses the upper limit of 240 mg daily, based on established evaluation of the standardized preparation. This daily amount may be administered as a single high-strength dose or divided into two or three smaller doses throughout the day (BID or TID) when using lower-strength units.

For proper consumption, the preparation is directed to be taken with or after food (meals). Tablets and capsules should be swallowed whole with water. If using the oral solution or drops, the dose must be accurately measured and mixed with water prior to ingestion. These practical instructions ensure the medicine is administered in a standardized manner.

Gincoben is part of a long-term management protocol. Guidelines recommend that a suitable duration of use, often at least 8 to 12 weeks, should pass before assessing the full effects of the treatment. Use is not recommended for children and adolescents under the age of 18 years, as it has been determined that there is insufficient data to support administration in these age groups.

Recent Clinical Evidence

Gincoben: Recent Clinical Evidence

Efficacy in Cognitive and Cerebrovascular Disorders

The majority of clinical research involving Gincoben (standardized Ginkgo biloba extract, often referenced as EGb 761) focuses on its use in age-related cognitive decline and dementia.

Studies have investigated whether the extract may be associated with improvements in cognitive function, including memory, processing speed, and attention, in patients with mild-to-moderate dementia.

  • Dementia/Cognitive Impairment: Several systematic reviews and meta-analyses suggest that the extract may contribute to the stabilization or slight improvement of cognitive performance and daily function during long-term administration (typically over 24 weeks). However, the evidence regarding its ability to prevent or substantially slow the progression of dementia remains contradictory across large-scale trials, with some showing no significant difference compared to placebo.

  • Peripheral Artery Disease: Clinical trials have explored the extract’s potential role in improving walking distance and pain-free walking time in patients with intermittent claudication, a symptom of peripheral artery disease. While some small studies reported a modest benefit, larger, well-designed trials have not consistently supported this effect.


Observed Safety Profile

The safety profile of the standardized Ginkgo biloba extract has been monitored across numerous clinical trials, often over long periods. Overall, the product is generally considered well-tolerated in most healthy adults when used for short durations.

  • Adverse Events: The most frequently reported adverse events are typically mild-to-moderate and include headache, dizziness, and gastrointestinal disturbances. More serious concerns, though rare, relate to the potential risk of bleeding, particularly when the extract is used in combination with anticoagulant or antiplatelet medications. Trial protocols often recommend discontinuing use prior to surgery due to this potential risk.

Key Studies & References

  1. Ginkgo biloba for preventing dementia: a randomized trial (The GEM Study)

Frequently Asked Questions (FAQ)

Common questions about Gincoben (FAQ)

Q: Are there any common reasons people stop taking Gincoben?

Official safety information indicates that mild-to-moderate adverse events such as headache, dizziness, or mild gastrointestinal upset are listed as common adverse events that may lead to discontinuation. In addition, regulatory warnings specify that the product is not suitable for individuals with certain pre-existing conditions, such as a bleeding disorder or epilepsy, which are identified as reasons for use to be restricted or discontinued.

Q: Are there any specific foods or drinks to avoid while using Gincoben?

Official guidance on administration notes that Gincoben should be taken either with or after food. Regulatory documentation does not list any specific foods, drinks, or beverages that must be strictly avoided while the medication is being used.

Q: Why does Gincoben need a prescription?

The regulatory classification of Gincoben can vary depending on the country or region. In some areas, this standardized extract is designated as a medicine that is only available on medical prescription. This classification ensures that a healthcare professional evaluates the product's use against a patient’s medical history before it is administered.

Q: Can Gincoben affect my sleep?

Sleep disturbances have been noted as a potential adverse event in some safety warnings associated with this standardized extract. While generally not listed among the most common adverse reactions, official documentation reports that sleep problems, such as insomnia, have been noted.

Q: Is Gincoben safe to take if I have high blood pressure?

Official product warnings indicate that caution is noted for patients concurrently taking medication to treat high blood pressure. Because potential interactions have been noted, regulatory guidance notes that consultation with a healthcare professional is necessary prior to beginning use.

Q: What happens if I miss a day of taking Gincoben?

Regulatory instructions provide guidance in the event of a missed dose. The documentation states that a patient should not take a double dose to compensate for a forgotten one. The next scheduled dose should be taken at the usual time as planned.

Q: Can Gincoben interact with supplements like fish oil or multivitamins?

Official warnings caution against using Gincoben alongside other supplements that may affect blood clotting properties. This includes natural health products such as garlic and ginger. Regulatory guidance stresses the need for review of all non-prescription items with a healthcare provider due to the potential for anti-platelet interaction.

Q: Does Gincoben have a warning about driving or operating machinery?

Regulatory product information states that it is not definitively known whether Gincoben impacts the ability to drive or operate machinery. The label advises that individuals first establish how the medicine affects them before undertaking these types of activities.

Q: Can Gincoben affect the results of lab tests?

Warnings related to Gincoben note the need for close monitoring of blood sugar levels for individuals taking diabetes medications. Because of this guidance, the medication may have an indirect effect on the regulation of blood glucose, which is a common laboratory test value.

Q: Can I take Gincoben if I have stomach issues like ulcers or gastritis?

Official safety documentation notes that general gastrointestinal disturbances are a common side effect of Gincoben. Furthermore, an interaction with certain acid-reducing medicines may reduce their effectiveness. This potential issue forms the basis for necessary consultation with a healthcare provider regarding use in patients with pre-existing stomach conditions.

Q: Does Gincoben come with a medication guide or patient leaflet?

Regulatory administration instructions consistently refer to the patient information leaflet for detailed guidance. This confirms that a comprehensive document, often called a Patient Information Leaflet (PIL) or medication guide, is provided with the product.

Q: Is it necessary to have follow-up bloodwork while taking Gincoben?

Official regulatory warnings note the need for close monitoring of blood sugar in patients who are concurrently taking diabetes medications. This necessary monitoring often involves follow-up bloodwork to check blood glucose levels and ensure they remain within an acceptable range.

How should Gincoben be stored and disposed of?

How to Store and Dispose of Gincoben?

The storage and disposal of Gincoben (standardized Ginkgo biloba extract) must comply with official regulatory labeling to ensure product stability and safety.


Mandatory Storage Conditions

Requirement Official Instruction
Temperature Do not store above 25 C.
Protection Store in the original package to protect from moisture and light.
Container Keep the container tightly closed when not in use.
Child Safety Keep out of the sight and reach of children and pets.

Official Disposal Rules

There are no special requirements for the disposal of the unused product. Contents and containers must be disposed of in accordance with local regulations and applicable pharmaceutical waste laws. The product should not be discharged into drains or water courses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gincoben found in:

A-Z Index: